$TMTC
TMT Acquisition Corp Stock $tmtc

$tmtc Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223017180 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$130.0K	$100.0K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$130.0K	$100.0K	$180.00
YoY Change	81150.0%		-98.2%
Operating Profit	-$133.8K	-$97.18K
YoY Change	85683.97%	359825.93%
Interest Expense	$600.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$470.0K	-$100.0K	-$180.00
YoY Change	-293850.0%		-98.2%
Income Tax
% Of Pretax Income
Net Earnings	$468.7K	-$97.18K	-$180.00
YoY Change	-293039.38%	359825.93%	-98.2%
Net Earnings / Revenue
Basic Earnings Per Share	$0.08	$43.62
Diluted Earnings Per Share	-$0.02	-$3.90	$0.00
COMMON SHARES
Basic Shares Outstanding	8.140M shares	133.3K shares
Diluted Shares Outstanding	2.140M shares	1.514M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$120.0K	$320.0K	$47.48K
YoY Change		136.25%
Cash & Equivalents	$0.00	$0.00	$0.00
Short-Term Investments
Other Short-Term Assets	$110.0K	$90.00K	$6.980K
YoY Change
Inventory
Prepaid Expenses	$114.1K	$87.20K	$6.979K
Receivables
Other Receivables		$34.32K
Total Short-Term Assets	$264.6K	$446.1K	$54.46K
YoY Change		229.38%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$61.80M	$61.20M
YoY Change
Other Assets	$30.00K	$40.00K	$443.3K
YoY Change		-88.28%
Total Long-Term Assets	$61.83M	$61.24M	$443.3K
YoY Change		17847.92%
TOTAL ASSETS
Total Short-Term Assets	$264.6K	$446.1K	$54.46K
Total Long-Term Assets	$61.83M	$61.24M	$443.3K
Total Assets	$62.10M	$61.69M	$497.7K
YoY Change		12841.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$125.6K	$187.3K	$38.62K
YoY Change		998.6%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$444.0K
YoY Change		-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$135.6K	$197.3K	$482.6K
YoY Change		-57.21%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$135.6K	$197.3K	$482.6K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$135.6K	$197.3K	$482.6K
YoY Change		-57.21%
SHAREHOLDERS EQUITY
Retained Earnings	-$240.9K	-$107.1K	-$9.897K
YoY Change
Common Stock	$214.00	$214.00	$173.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$156.9K	$290.7K	$15.10K
YoY Change
Total Liabilities & Shareholders Equity	$62.10M	$61.69M	$497.7K
YoY Change		12841.46%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q4
OPERATING ACTIVITIES
Net Income	$468.7K	-$97.18K	-$180.00
YoY Change	-293039.38%	359825.93%	-98.2%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$210.0K	-$60.59K	-$3.920K
YoY Change		544.6%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$61.20M
YoY Change
Cash From Investing Activities	$0.00	-$61.20M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	$61.54M	-2.620K
YoY Change		-111682.5%	-101.31%
NET CHANGE
Cash From Operating Activities	-210.0K	-$60.59K	-3.920K
Cash From Investing Activities	0.000	-$61.20M
Cash From Financing Activities	0.000	$61.54M	-2.620K
Net Change In Cash	-210.0K	$277.2K	-6.540K
YoY Change		-529.36%	-103.27%
FREE CASH FLOW
Cash From Operating Activities	-$210.0K	-$60.59K	-$3.920K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001879851
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent		usd
CY2023Q1	us-gaap	Other Receivable After Allowance For Credit Loss Current Related And Nonrelated Party Status Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Receivable After Allowance For Credit Loss Current Related And Nonrelated Party Status Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent		usd
CY2023Q1	us-gaap	Deferred Costs DeferredCosts		usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent		usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2023Q1	us-gaap	Other Receivable After Allowance For Credit Loss Current Related And Nonrelated Party Status Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Receivable After Allowance For Credit Loss Current Related And Nonrelated Party Status Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2023Q1	us-gaap	Other Receivable After Allowance For Credit Loss Current Related And Nonrelated Party Status Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Other Receivable After Allowance For Credit Loss Current Related And Nonrelated Party Status Extensible Enumeration OtherReceivableAfterAllowanceForCreditLossCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital		usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q1	us-gaap	Administrative Fees Expense AdministrativeFeesExpense		usd
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic		shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic
CY2023Q1	TMTCU	Stock Issued During Period Value Forfeiture Of Ordinary Shares StockIssuedDuringPeriodValueForfeitureOfOrdinaryShares		usd
CY2022Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
CY2022Q1	TMTCU	Cash Deposited Into Trust Account CashDepositedIntoTrustAccount		usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2022Q1	TMTCU	Payment Of Underwriting Discount PaymentOfUnderwritingDiscount		usd
CY2023Q1	TMTCU	Reclassification Of Amount Due To Related Party To Promissory Note ReclassificationOfAmountDueToRelatedPartyToPromissoryNote		usd
CY2022Q1	TMTCU	Deferred Offering Costs Included In Accrued Expenses DeferredOfferingCostsIncludedInAccruedExpenses		usd
CY2022Q1	TMTCU	Note Payable To Related Party Converted To Subscription Of Private Placement NotePayableToRelatedPartyConvertedToSubscriptionOfPrivatePlacement		usd
CY2022Q1	TMTCU	Receivable From Related Party For Purchase Of Private Placement ReceivableFromRelatedPartyForPurchaseOfPrivatePlacement		usd
CY2022Q1	TMTCU	Allocation Of Offering Costs To Ordinary Shares Subject To Redemption AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption		usd
CY2022Q1	TMTCU	Reclassification Of Ordinary Shares Subject To Redemption ReclassificationOfOrdinarySharesSubjectToRedemption		usd
CY2022Q1	TMTCU	Remeasurement Adjustment On Ordinary Shares Subject To Possible Redemption RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption		usd
CY2022Q1	TMTCU	Issuance Of Representative Shares At Fair Value IssuanceOfRepresentativeSharesAtFairValue		usd
CY2022Q1	TMTCU	Forfeiture Of Ordinary Shares ForfeitureOfOrdinaryShares		usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2022Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-41667
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	TMT Acquisition Corp
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	420 Lexington Ave
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 2446
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10170
CY2023Q1	dei	City Area Code CityAreaCode	(347)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	627-0058
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8140000	shares
CY2023Q1	us-gaap	Cash Cash	324632	usd
CY2022Q4	us-gaap	Cash Cash	47478	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	87195	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6979	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	34318	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	446145	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	54457	usd
CY2023Q1	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	41889	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	443284	usd
CY2023Q1	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	61200000	usd
CY2023Q1	us-gaap	Assets Assets	61688034	usd
CY2022Q4	us-gaap	Assets Assets	497741	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	187312	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	38620	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	444018	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	197312	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	482638	usd
CY2023Q1	us-gaap	Liabilities Liabilities	197312	usd
CY2022Q4	us-gaap	Liabilities Liabilities	482638	usd
CY2023Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	6000000	shares
CY2022Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	6000000	shares
CY2023Q1	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	10.20
CY2022Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	10.20
CY2023Q1	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	61200000	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2140000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2140000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1725000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1725000	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	214	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	173	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	397585	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24827	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-107077	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9897	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	290722	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15103	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	47478	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	61688034	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	497741	usd
CY2023Q1	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	10000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	87180	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-97180	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-27	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-97180	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-27	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	133333	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	43.62
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1514222	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1500000	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.90
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	15103	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-27	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-15602	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-15602	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15103	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15103	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	60000000	usd
CY2023Q1	TMTCU	Stock Issued During Period Value Proceeds From Sale Of Private Placement Units StockIssuedDuringPeriodValueProceedsFromSaleOfPrivatePlacementUnits	3700000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-1200000	usd
CY2023Q1	TMTCU	Stock Issued During Period Value Representative Shares Issued StockIssuedDuringPeriodValueRepresentativeSharesIssued	1741500	usd
CY2023Q1	TMTCU	Adjustments To Additional Paid In Capital Other Offering Costs AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts	-2668701	usd
CY2023Q1	TMTCU	Stock Issued During Period Value Initial Measurement Of Ordinary Shares Subject To Redemption Against Additional Paidin Capital StockIssuedDuringPeriodValueInitialMeasurementOfOrdinarySharesSubjectToRedemptionAgainstAdditionalPaidinCapital	-58645200	usd
CY2023Q1	TMTCU	Adjustments To Additional Paid In Capital Allocation Of Offering Costs To Ordinary Shares Subject To Redemption AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption	3781346	usd
CY2023Q1	TMTCU	Adjustments To Additional Paid In Capital Deduction For Increases Of Carrying Value Of Redeemable Shares AdjustmentsToAdditionalPaidInCapitalDeductionForIncreasesOfCarryingValueOfRedeemableShares	-6336146	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-97180	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	290722	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	290722	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-97180	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-27	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	10000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	122105	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	148693	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-9371	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-60592	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9398	usd
CY2023Q1	TMTCU	Cash Deposited Into Trust Account CashDepositedIntoTrustAccount	61200000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-61200000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	60000000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	3221664	usd
CY2023Q1	TMTCU	Payment Of Underwriting Discount PaymentOfUnderwritingDiscount	1200000	usd
CY2023Q1	TMTCU	Payment Of Offering Costs PaymentOfOfferingCosts	483918	usd
CY2022Q1	TMTCU	Payment Of Offering Costs PaymentOfOfferingCosts	55150	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	61537746	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-55150	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	277154	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-64548	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	200000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	324632	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	135452	usd
CY2022Q1	TMTCU	Reclassification Of Amount Due To Related Party To Promissory Note ReclassificationOfAmountDueToRelatedPartyToPromissoryNote	244018	usd
CY2023Q1	TMTCU	Deferred Offering Costs Included In Accrued Expenses DeferredOfferingCostsIncludedInAccruedExpenses	2668701	usd
CY2023Q1	TMTCU	Note Payable To Related Party Converted To Subscription Of Private Placement NotePayableToRelatedPartyConvertedToSubscriptionOfPrivatePlacement	444018	usd
CY2023Q1	TMTCU	Receivable From Related Party For Purchase Of Private Placement ReceivableFromRelatedPartyForPurchaseOfPrivatePlacement	34318	usd
CY2023Q1	TMTCU	Allocation Of Offering Costs To Ordinary Shares Subject To Redemption AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption	3781346	usd
CY2023Q1	TMTCU	Reclassification Of Ordinary Shares Subject To Redemption ReclassificationOfOrdinarySharesSubjectToRedemption	58645200	usd
CY2023Q1	TMTCU	Remeasurement Adjustment On Ordinary Shares Subject To Possible Redemption RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption	6336146	usd
CY2023Q1	TMTCU	Issuance Of Representative Shares At Fair Value IssuanceOfRepresentativeSharesAtFairValue	1741500	usd
CY2023Q1	TMTCU	Forfeiture Of Ordinary Shares ForfeitureOfOrdinaryShares	23	usd
CY2023Q1	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2021-07-06
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.20
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.20
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.20
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.20
CY2023Q1	TMTCU	Cash Deposited Into Trust Account CashDepositedIntoTrustAccount	61200000	usd
CY2023Q1	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	3868701	usd
CY2023Q1	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	1200000	usd
CY2023Q1	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	2668701	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	324632	usd
CY2023Q1	us-gaap	Cash Cash	324632	usd
CY2023Q1	TMTCU	Working Capital WorkingCapital	248833	usd
CY2023Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	25000	usd
CY2023Q1	us-gaap	Proceeds From Unsecured Notes Payable ProceedsFromUnsecuredNotesPayable	444018	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_846_eus-gaap--UseOfEstimates_zOqt5apaqcCd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zpVh6oTTtR54">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	usd
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zYAAjI3e06Jd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zh543P3AOnkh">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_90F_eus-gaap--CashFDICInsuredAmount_iI_c20230331_z6kyNhalNEAi" title="Cash FDIC insured amount"><span id="xdx_90E_eus-gaap--CashFDICInsuredAmount_iI_c20221231_ze5BCywX8ae1" title="Cash FDIC insured amount">250,000</span></span>. At March 31, 2023 and December 31, 2022, the Company did not experience losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-97180	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-27	usd
CY2023Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	6336146	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6433326	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-27	usd
CY2023Q1	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.20
CY2023Q1	us-gaap	Net Shares Reclassified To Mandatorily Redeemable Capital Stock Value NetSharesReclassifiedToMandatorilyRedeemableCapitalStockValue	3781346	usd
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1725000	shares
CY2023Q1	TMTCU	Business Acquisitions Name Of Acquired Entity BusinessAcquisitionsNameOfAcquiredEntity	The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination and (B) the date on which we complete a liquidation, merger, share exchange, reorganization or other similar transaction after our initial business combination that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the last reported sale price of the ordinary shares equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Business Combination.
CY2023Q1	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	10000	usd
CY2023Q1	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	10000	usd
CY2023Q1	us-gaap	Underwriting Commitments UnderwritingCommitments	The underwriters were entitled to a cash underwriting discount of $0.20 per Unit, or $1,200,000 in the aggregate, which was paid upon the closing of the Initial Public Offering.
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Common Stock Voting Rights CommonStockVotingRights	Holders of Class A and Class B ordinary shares were entitled to one vote for each share.
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2140000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2140000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1725000	shares
CY2023Q1	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	Simultaneously with the closing of the IPO, the Company issued to Maxim Partners LLC, pursuant to the underwriting agreement, 270,000 Representative Shares (the “Representative Shares”). The underwriter has agreed not to transfer, assign or sell any such Representative Shares without prior consent of the Company until the completion of the initial Business Combination.
CY2023Q1	TMTCU	Fair Value Of Representative Shares FairValueOfRepresentativeShares	1741500	usd

Files In Submission

Name	View Source	Status
tmtcu-20230331_cal.xml	Edgar Link	unprocessable
0001493152-23-017180-index-headers.html	Edgar Link	pending
0001493152-23-017180-index.html	Edgar Link	pending
0001493152-23-017180.txt	Edgar Link	pending
0001493152-23-017180-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tmtcu-20230331.xsd	Edgar Link	pending
tmtcu-20230331_def.xml	Edgar Link	unprocessable
tmtcu-20230331_lab.xml	Edgar Link	unprocessable
tmtcu-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TMTC
TMT Acquisition Corp Stock $tmtc

2023 Q2 Form 10-Q Financial Statement

#000149315223017180 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TMTC TMT Acquisition Corp Stock $tmtc

2023 Q2 Form 10-Q Financial Statement

#000149315223017180 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TMTC
TMT Acquisition Corp Stock $tmtc